Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
COST OF RHEUMATOID ARTHRITIS PATIENTS RECEIVING TNF-ANTAGONIST THERAPY FROM THE KOREA NATIONAL HEALTH INSURANCE CLAIMS DATABASE
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Park, S. J. | - |
| dc.contributor.author | Lee, E. K. | - |
| dc.date.available | 2021-02-22T13:17:33Z | - |
| dc.date.issued | 2011-05 | - |
| dc.identifier.issn | 1098-3015 | - |
| dc.identifier.issn | 1524-4733 | - |
| dc.identifier.uri | https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/12589 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | ELSEVIER SCIENCE INC | - |
| dc.title | COST OF RHEUMATOID ARTHRITIS PATIENTS RECEIVING TNF-ANTAGONIST THERAPY FROM THE KOREA NATIONAL HEALTH INSURANCE CLAIMS DATABASE | - |
| dc.type | Article | - |
| dc.publisher.location | 미국 | - |
| dc.identifier.doi | 10.1016/j.jval.2011.02.701 | - |
| dc.identifier.wosid | 000299105000659 | - |
| dc.identifier.bibliographicCitation | VALUE IN HEALTH, v.14, no.3, pp A125 - A126 | - |
| dc.citation.title | VALUE IN HEALTH | - |
| dc.citation.volume | 14 | - |
| dc.citation.number | 3 | - |
| dc.citation.startPage | A125 | - |
| dc.citation.endPage | A126 | - |
| dc.type.docType | Meeting Abstract | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | ssci | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Business & Economics | - |
| dc.relation.journalResearchArea | Health Care Sciences & Services | - |
| dc.relation.journalWebOfScienceCategory | Economics | - |
| dc.relation.journalWebOfScienceCategory | Health Care Sciences & Services | - |
| dc.relation.journalWebOfScienceCategory | Health Policy & Services | - |
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - ETC > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.